OTCMKTS:SWTUY - SWEDISH ORPHAN/S Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$24.38
▼ -0.29 (-1.18%)

This chart shows the closing price for SWTUY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SWEDISH ORPHAN/S Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SWTUY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SWTUY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for SWEDISH ORPHAN/S in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $24.38.

This chart shows the closing price for SWTUY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in SWEDISH ORPHAN/S. This rating has held steady since November 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/31/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/10/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
(Data available from 6/23/2016 forward)
SWEDISH ORPHAN/S logo
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.
Read More

Today's Range

Now: $24.38
Low: $24.38
High: $24.38

50 Day Range

MA: $24.39
Low: $24.38
High: $24.67

52 Week Range

Now: $24.38
Low: $18.50
High: $31.96

Volume

200 shs

Average Volume

1,665 shs

Market Capitalization

$6.64 billion

P/E Ratio

48.76

Dividend Yield

N/A

Beta

1.81

Frequently Asked Questions

What sell-side analysts currently cover shares of SWEDISH ORPHAN/S?

The following Wall Street sell-side analysts have issued reports on SWEDISH ORPHAN/S in the last year:
View the latest analyst ratings for SWTUY.

What is the current price target for SWEDISH ORPHAN/S?

0 Wall Street analysts have set twelve-month price targets for SWEDISH ORPHAN/S in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for SWEDISH ORPHAN/S in the next year.
View the latest price targets for SWTUY.

What is the current consensus analyst rating for SWEDISH ORPHAN/S?

SWEDISH ORPHAN/S currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SWTUY.

What other companies compete with SWEDISH ORPHAN/S?

How do I contact SWEDISH ORPHAN/S's investor relations team?

SWEDISH ORPHAN/S's physical mailing address is Tomtebodavagen 23A, Stockholm V7, 112 76. The company's listed phone number is 46-0-869-720-00 and its investor relations email address is [email protected] The official website for SWEDISH ORPHAN/S is www.sobi.com.